Growing U.S. Customer Base Surpasses 660 Sites
DENVER, Dec. 3 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today announced that its Wyndgate Technologies(R) division has signed an agreement to license its transfusion management system SafeTrace Tx(R) to Sheridan Memorial Hospital, of Sheridan, Wyoming. Sheridan Memorial Hospital (Sheridan) joins a growing customer site base, now numbering over 660 in the United States. Terms of the agreement were not disclosed.
"Patient safety and confidence in the product were the top reasons for choosing Wyndgate," cited Gary Sellenrick, MT(ASCP), Laboratory Manager for Sheridan Memorial Hospital. "The inventory tracking features in SafeTrace Tx will allow Sheridan to utilize computer systems to help reduce errors in the lab as well as accurately track blood distribution throughout our facility." Sellenrick continued, "We were also looking for a stand-alone system that would interface with our Orchard LIS. We decided on SafeTrace Tx early in the process because of Wyndgate's experience in converting paper records to an automated system as well as their prior success interfacing with Orchard systems."
Sheridan Memorial Hospital is upgrading its blood bank from paper records to an automated system in conjunction with an initiative to increase patient safety. The organization has also purchased a laboratory information system (LIS) developed by Orchard in order to take advantage of new technologies and features which promote efficiency and patient safety. The SafeTrace Tx system will communicate with Sheridan's new LIS to allow the blood bank and other departments throughout the hospital to share patient information quickly and easily.
SafeTrace Tx is uniquely designed to support the full scale of transfusion services from enterprise-wide centralized facilities to small, individual hospital laboratories. Advanced functionality in SafeTrace Tx, such as electronic crossmatch, automated patient special needs tracking and antigen/antibody functionality, will assist Sheridan in matching patients for transfusions.
Wm. Scott Dustin, Vice President of Sales and Marketing for Wyndgate Technologies, commented, "Wyndgate Technologies supports Sheridan Memorial Hospital's mission to convert to a paperless system, an important step in elevating hospital operations and patient care to a new level. Working with the people of Sheridan Memorial, the Wyndgate team has developed a deep respect for the care and dedication Sheridan has for the patients they serve." Mr. Dustin continued, "Wyndgate is proud to be participating in this project with Sheridan and our channel partner Orchard to provide a blood management system which will allow the blood bank and other departments throughout the hospital to interface more productively."
Additionally, Dr. Mick Ruxin, CEO of Global Med Technologies, commented, "Sheridan Memorial Hospital is representative of the great client potential from the 15% to 20% of U.S. hospitals whose blood bank systems are still run on paper, besides those that are on outdated, legacy electronic systems."
About Sheridan Memorial Hospital
Sheridan Memorial Hospital is a community-based facility in Sheridan, Wyoming. Dedicated in 1954, the completed hospital fulfilled the dreams of over 300 volunteers whose years of dedication made the facility a reality. Today, Sheridan provides the latest in medical technology, much of which was beyond imagination in 1954. This includes kidney dialysis, MRI, CT, nuclear imaging, same-day surgery, critical care, a sleep lab, and cancer therapy, to name just a few.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R) advanced transfusion management system, recently patented, provide Vein-to-Vein(R) tracking from donor collection to patient transfusion.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
|SOURCE Global Med Technologies, Inc.|
Copyright©2007 PR Newswire.
All rights reserved